Evidence map›Paper›PMID 17411369›Full record

ArticleAIDS research and human retroviruses2007

Clinical manifestations associated with HTLV type I infection: a cross-sectional study.

Marina F Caskey, Daniel J Morgan, Aurelia F Porto, Silvana P Giozza, Andre L Muniz, Glória O Orge, Maria J Travassos, Yolanda Barrón, Edgar M Carvalho, Marshall J Glesby

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in AIDS research and human retroviruses, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01640002 (A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive Bladder), which is not on this map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01640002 phase1unknown statusnot on this mapstarted 2012, after this paper: background citation

A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive Bladder

TypeinterventionalSponsorHospital Universitário Professor Edgard SantosRan2012 to 2013Enrolled42ConditionsOveractive Bladder Associated With HTLV-1ArmsPropantheline Bromide, Placebo
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it, 82 citations in OpenAlex.

  1. HTLV-1-associated diseases: a systematic review.Revista do Instituto de Medicina Tropical de Sao Paulo · 2026
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Cognitive deficits in HTLV-1 patients.Journal of neurovirology · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Marina F CaskeyDivision of International Medicine and Infectious Diseases, Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021, USA.
Daniel J Morgan
Aurelia F Porto
Silvana P Giozza
Andre L Muniz
Glória O Orge
Maria J Travassos
Yolanda Barrón
Edgar M Carvalho
Marshall J Glesby
Universidade Federal da Bahia · BRCornell University · USComplexo Hospitalar Universitário Professor Edgard Santos · BR

Funding

T32: Pathogenesis of Infectious Diseases Training ProgramT32AI007613 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI ROY M. GULICK · 1999 to 2026
$8.8M
Immunological Response and Disease Expression in HTLV-1R03AI060830 · NIAID · FEDERAL UNIVERSITY OF BAHIA · PI CARVALHO, EDGAR M · 2005 to 2006
$107k
NIAID NIH HHS R03 AI060830NIAID NIH HHS R03-AI60830NIAID NIH HHS T32 AI007613NIAID NIH HHS T32-AI07613
6 · The paper itself

Abstract

Human T-lymphotropic virus type I (HTLV-I) causes HTLV-I-associated myelopathy/tropical spastic paraparesis and adult T cell leukemia in a small percentage of infected individuals. HTLV-I infection is increasingly associated with clinical manifestations. To determine the prevalence of clinical manifestations in HTLV-I infected individuals, we conducted a cross-sectional study of 115 HTLV-I-infected blood donors without myelopathy and 115 age- and sex-matched seronegative controls. Subjects answered a standardized questionnaire and underwent physical examination. Compared with controls, HTLV-I-infected subjects were more likely to report arm or leg weakness (OR = 3.8, 95% CI: 1.4-10.2; OR = 4.0, 95% CI: 1.6-9.8, respectively), hand or foot numbness (OR = 2.1, 95% CI: 1.1-3.9; OR = 4.8, 95% CI: 2.0-11.7, respectively), arthralgia (OR = 3.3, 95% CI: 1.7-6.4), nocturia (OR = 2.7, 95% CI: 1.04-6.8), erectile dysfunction (OR = 4.0, 95% CI: 1.6-9.8), and to have gingivitis (OR = 3.8, 95% CI: 1.8-7.9), periodontitis (OR = 10.0, 95% CI: 2.3-42.8), and dry oral mucosa (OR = 7.5, 95% CI: 1.7-32.8). HTLV-I infection is associated with a variety of clinical manifestations, which may occur in patients who have not developed myelopathy.

Indexed as

AdultArthralgiaBlood DonorsCarrier StateCase-Control StudiesCross-Sectional StudiesErectile DysfunctionFemaleHTLV-I InfectionsHumansHuman T-lymphotropic virus 1HypesthesiaMaleMiddle AgedMuscle WeaknessNocturia

Identifiers

PMID17411369
PMCPMC2593454
OpenAlexW2071774452

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.